Physician profile

Theodore M Whitaker

Internal Medicine · Overland Park, KS

NPI 1164413167

$3,666.53

in general payments reported to CMS, 2019-2025

32 companies · none reported in 2025

See the full distribution for Internal Medicine

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Amgen INC. $630.52 2019-2021
Novo Nordisk INC $425.42 2019-2021
Abbvie INC. $394.65 2019-2021
Amarin Pharma, INC. $268.30 2019-2021
Astrazeneca Pharmaceuticals LP $169.21 2019-2020
Lilly USA, LLC $165.87 2019-2021
Pfizer INC. $138.17 2019-2021
Biohaven Pharmaceuticals, INC. $134.09 2020-2021
Sanofi-Aventis U.S. LLC $124.81 2019-2021
Radius Health, INC. $122.09 2019
Glaxosmithkline, LLC. $121.36 2019
Janssen Pharmaceuticals, INC $112.31 2019-2021
Merck Sharp & Dohme LLC $111.69 2019-2021
Nestle Healthcare Nutrition INC. $98.72 2021
Allergan, INC. $97.51 2019-2020
Show all 32 companies

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Theodore M Whitaker

$3,666.53

in general payments reported 2019-2025

Years
2019-2021
Top company
Amgen INC.

https://glasscript.com/doctor/98211/theodore-m-whitaker

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.